ESTUDIO EN FASE III MULTICÉNTRICO Y DE EXTENSIÓN A LARGO PLAZO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE PF-04965842, EN MONOTERAPIA O EN COMBINACIÓN CON MEDICAMENTOS TÓPICOS, ADMINISTRADO A PACIENTES DE 12 AÑOS O MÁS CON DERMATITIS ATÓPICA MODERADA O GR AVE.

Letter. 10.1111/jdv.16664. 2020

A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain

Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro

Article. 10.33393/grhta.2022.2333. 2022

A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.

Zozaya, Neboa; (...); Verde, Luis

Article. 10.1017/S0266462322000459. 2022

A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.

de Andrés-Nogales F; (...); Martínez-Olmos J

Article. 10.1007/s41669-020-00201-2. 2020

A new definition and refocus of pharmaceutical care: the Barbate Document

Morillo-Verdugo R; (...); Poveda-Andrés JL

Article. 10.7399/fh.11389. 2020

A prospective multicenter study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients

Ortiz-Salvador, JM; (...); Perez-Ferriols, A

Article. 10.1016/j.jaad.2019.02.062. 2019

A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.

Dirschka T; (...); Puig S

Article. 10.1111/jdv.15185. 2019

A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis

Canueto, J; (...); Sanmartin, O

Review. 10.1016/j.ad.2019.06.005. 2020

Absolute PASI and secukinumab in plaque psoriasis: Experience of clinical practice in a tertiary Hospital of Valencia, Spain

Piqueras-Garcia, J; (...); BotellaEstrada, R

Meeting Abstract. 2019

Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis

Torres-Navarro, I; (...); Botella-Estrada, R

Article. 10.1111/1346-8138.15490. 2020

Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis

Torres-Navarro, I, Briz-Redon, A, Botella-Estrada, R

Review. 10.1111/jdv.16137. 2020

Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.

Ballesta-López O; (...); Poveda-Andrés JL

Article. 10.1177/1078155220915953. 2020

Advanced type 1 hyperoxaluria presenting as livedo racemosa in a patient with end-stage renal disease

Torres-Navarro, I; (...); Moral-Moral, P

Letter. 10.4103/ijdvl.IJDVL_1030_18. 2019

Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain.

Tous-Romero, Fatima; (...); Ortiz-de Frutos, Francisco Javier

Letter. 10.1111/jdv.18595. 2022

Analysing criteria for price and reimbursement of orphan drugs in Spain.

Badia, X; (...); Tort, M

Article. 10.7399/fh.11147. 2019

Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/10781552211038518. 2021

Anti-Mi-2 Dermatomyositis with ulcerative plaques.

Palacios-Diaz RD; (...); Botella-Estrada, Rafael

Article. 10.1093/rheumatology/keac180. 2022

Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023

Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic

Roca-Gines, J; (...); Evole-Buselli, M

Article. 10.1001/jamadermatol.2020.2340. 2020

Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study

Avallone, Gianluca; (...); Quaglino, Pietro

Article. 10.2340/actadv.v102.319. 2022

Atypical bullae in hands and trunk: An unusual suspect.

Palacios-Diaz, Rodolfo David, Lasheras-Perez, Miguel Antonio, Rodriguez-Serna, Mercedes

Case Reports. 10.1016/j.eimce.2023.12.003. 2024

Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021

Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Mansilla-Polo, Miguel, Martin-Torregrosa, Daniel, Botella-Estrada, Rafael

Article. 10.1016/j.thromres.2018.12.027. 2019

Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022

BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings.

Munera-Campos M; (...); Carrascosa JM

Article. 10.1016/j.ad.2023.03.001. 2023

Candidate Allergens for Inclusion in the Spanish Standard Series Based on Data from the Spanish Contact Dermatitis Registry.

Hernández-Fernández CP; (...); Borrego Hernando L

Article. 10.1016/j.ad.2021.05.005. 2021

Casal necklace.

Article. 10.1016/j.medcli.2023.03.035. 2023

Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group

Sahuquillo-Torralba, Antonio; (...); Gallardo, Fernando

Article. 10.1111/ijd.17238. 2024

Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Article. 10.1016/j.thromres.2021.07.009. 2021

Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

Sanmartin, O; (...); Gravalos, C

Article. 10.1016/j.ad.2019.01.011. 2019

Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

Gravalos, C; (...); Botella, R

Article. 10.1007/s12094-018-1953-x. 2019

Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019

Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV).

Botella-Estrada R; (...); García-Doval I

Article. 10.1016/j.ad.2020.07.003. 2021

Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-alpha inhibitors.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.1111/ddg.15007. 2023

Coma blisters. A key to neurological diagnosis.

Letter. 10.1016/j.nrl.2018.11.005. 2020

Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19

Torres-Navarro, I; (...); Evole-Buselli, M

Letter. 10.1111/ced.14255. 2020

Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Meeting Abstract. 2020

Complete response of a locally advanced basosquamous carcinoma with vismodegib treatment

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Letter. 10.4103/ijdvl.IJDVL_647_18. 2019

Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS

Ruiz-Salas, Veronica; (...); Garcia-Doval, Ignacio

Article. 10.1159/000517010. 2021

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023

Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients A Delphi Consensus Statement

Massey, Paul R.; (...); Jambusaria-Pahlajani, Anokhi

Article. 10.1001/jamadermatol.2021.3180. 2021

Contact allergy to formaldehyde releasers. Prospective multicenter study.

Sanz-Sánchez T; (...); Arnau AMG

Editorial Material. 10.1111/cod.13417. 2020

Contact dermatitis by face mask.

Mansilla-Polo M, Navarro-Mira MÁ, Botella-Estrada R

Article. 10.1016/j.medcli.2023.01.004. 2023

Correction: 'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.

Correction. 10.1007/s15010-024-02259-0. 2024

Corrigendum to "Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients" [Clin. Biomech. volume 68 (2019) Pages 169-174/Article Number JCLB 4795].

Olmos CMF; (...); Ivorra JAR

Correction. 10.1016/j.clinbiomech.2019.10.023. 2020

COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020

COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020

Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021

Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis

Letter. 10.1111/hae.13733. 2019

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019

Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.

Garrido-Jareño M; (...); Pemán-García J

Article. 10.1186/s13071-020-3901-1. 2020

Cutaneous larva migrans.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1016/j.medcli.2023.03.037. 2023

Cutaneous sarcoidosis after platelet-rich plasma injections and permanent eyebrow make-up.

Torregrosa DM; (...); Estrada RB

Case Reports. 10.1016/j.ad.2023.06.023. 2024

Cyclosporine 0.1% (Ikervis ) treatment in steroid-dependent dupilumab-associated conjunctivitis.

Roca-Ginés J; (...); Navarro-Mira MÁ

Article. 10.1016/j.oftal.2019.04.013. 2019

Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm Registry.

Ruiz-Genao DP; (...); García-Doval I

Article. 10.1016/j.ad.2020.05.008. 2020

Characterizing chronic hepatitis delta in Spain and the gaps in its management

Rodriguez-Tajes, Sergio; (...); Lens, Sabela

Meeting Abstract. 2023

Characterizing Hepatitis Delta in Spain and the gaps in its management.

Rodriguez-Tajes, Sergio; (...); Lens, Sabela

Article. 10.1016/j.gastrohep.2024.502222. 2024

Chikungunya fever with a positive tourniquet test: a novel description.

Article. 10.1093/ced/llae089. 2024

Dermatologic consultations for patients hospitalized in non-dermatologic wards: results of a 384-patient cross-sectional study from a tertiary referral hospital.

Mansilla-Polo, M; (...); Botella-Estrada, R

Case Reports. 10.1016/j.ad.2023.11.021. 2023

Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021

Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019

DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019

Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019

Development and validation of a model to predict complex Mohs Micrographic Surgery in clinical practice: REGESMOSH scale.

Montero-Vilchez, Trinidad R.; (...); Sanmartin-Jimenez, Onofre

Article. 10.1111/jdv.19056. 2023

Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019

Development of severity and mortality prediction models for covid-19 patients at emergency department including the chest x-ray.

Calvillo-Batllés P; (...); Martí-Bonmatí L

Article. 10.1016/j.rxeng.2021.09.004. 2022

Diagnosis of Lung Cancer Due to a Complicated Abscess.

Torres-Navarro I, Piqueras-García J, Botella-Estrada R

Editorial Material. 10.1016/j.ad.2018.01.020. 2019

Differences in epidemiology, comorbidities and treatment choice between plaque psoriasis and pustular psoriasis: results from the Biobadaderm registry.

Ruiz Genao, Diana P.; (...); Garcia-Doval, Ignacio

Letter. 10.1111/bjd.21763. 2022

DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis

Sanz-Garcia, A; (...); Ovejero-Benito, MC

Article. 10.2340/00015555-3794. 2021

Does hyaluronidase injected in periocular area change skin ultrastructure?: Standardized in vitro analysis

Aguilar-González M; (...); Pérez-López M

Article. 10.1111/jocd.15014. 2022

Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting

Daudén E; (...); Llamas-Velasco M

Article. 10.1111/ijd.16915. 2024

Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study

Lasheras-Pérez MA; (...); Rodríguez-Serna M

Article. 10.1111/ijd.17030. 2024

Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.

Phan, Duc Binh; (...); Yiu ZZN

Article. 10.1136/bmjopen-2023-075197. 2023

Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).

Rodriguez, C Couselo; (...); Florez, A.

Article. 10.1016/j.ad.2023.07.014. 2023

Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study

Lopez-Ferrer, Anna; (...); Puig, Lluis

Article. 10.1111/dth.15831. 2022

Dupilumab for atopic dermatitis during pregnancy and breastfeeding: Clinical experience in 13 patients.

Escolà H; (...); Curto-Barredo L

Letter. 10.1111/jdv.19165. 2023

Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020

Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort

Hernandez-Fernandez, CP; (...); Garcia-Doval, I

Article. 10.2340/00015555-3711. 2021

Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population.

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Article. 10.1111/ajd.14130. 2023

Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.

del Alcazar, Elena; (...); Carrascosa YJM

Article. 10.1111/dth.15231. 2022

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

Casanova MJ; (...); Gisbert JP

Article. 10.1093/ibd/izz192. 2020

Effectiveness and Safety of the Switch from Remicade (R) to CT-P13 in Patients with Inflammatory Bowel Disease

Chaparro, M; (...); Gisbert, JP

Article. 10.1093/ecco-jcc/jjz070. 2019

Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021

Effectiveness of Secukinumab for the treatment of erythrodermic psoriasis. Multicenter study in daily practice.

Reymundo, A; (...); Dauden, E

Letter. 10.1111/jdv.19371. 2023

Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice.

Letter. 10.1111/ajd.14151. 2023

Emicizumab-induced photosensitivity.

Asensi Canto, Pedro; (...); Haya Guaita, Saturnino

Article. 10.1055/s-0042-1749092. 2022

EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.

Chaparro M; (...); Gisbert JP

Article. 10.1177/1756284819847034. 2019

Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC).

Verdaguer-Faja J; (...); Carrascosa JM

Article. 10.1016/j.ad.2024.02.009. 2024

Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC).

Mora-Fernandez, V; (...); Carrascosa, J. M.

Article. 10.1016/j.ad.2021.10.002. 2022

Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Chaparro, M; (...); EpidemIBD Grp

Meeting Abstract. 10.1093/ecco-jcc/jjy222.914. 2019

Erfolgreiche Imatinib-Therapie einer mit dem myeloproliferativen hypereosinophilen Syndrom mit PDGFRA-Rearrangement assoziierten lymphomatoiden Papulose

Mansilla-Polo M, Botella-Estrada R

Letter. 10.1111/ddg.14064_g. 2020

Erythema Elevatum Diutinum.

Article. 10.1016/j.ad.2023.10.042. 2024

EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019

Evaluation of pneumatosis intestinalis as a complication of lung transplantation

Ripolles, V. Belloch; (...); Marti-Bonmati, Y. L.

Article. 10.1016/j.rx.2023.01.006. 2024

EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019

Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting

Chicharro, Pablo; (...); Dauden, Esteban

Article. 10.1111/dth.15653. 2022

Fatal outcome in classic Kaposi's sarcoma.

Mansilla-Polo M, Botella-Estrada R

Article. 10.1016/j.ad.2023.03.013. 2024

Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021

Folliculotropic Mycosis Fungoides With Flexural Eruptive Cysts and Comedones in a 14-Year-Old Boy.

Roca-Gines, J; (...); Botella-Estrada, R

Article. 10.1097/DAD.0000000000001958. 2021

Four-year epidemiological surveillance of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC): Current situation and trends.

Romero FT; (...); de Frutos JO

Article. 10.1016/j.ad.2023.10.039. 2024

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease

Chaparro, M; (...); Gisbert, JP

Meeting Abstract. 2019

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease.

Chaparro M; (...); Gisbert JP

Article. 10.1177/1756284819867848. 2019

Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024

Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022

Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022

Hemihypoatrophy as an extraordinary manifestation of linear morphoea.

Mansilla-Polo, Miguel, Navarro-Mira, Miguel A., Botella-Estrada, Rafael

Article. 10.1093/rap/rkac104. 2022

Heparin hemorrhagic bullae induced by enoxaparin.

Torres-Navarro I, de Unamuno-Bustos B, Pujol-Marco C

Letter. 10.1016/j.medcli.2019.09.012. 2019

Herpes vegetans of the vulva.

Abril-Pérez C; (...); Botella-Estrada R

Article. 10.1016/j.ajog.2021.05.024. 2021

High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting

Martos-Cabrera, Luisa; (...); Dauden, Esteban

Letter. 10.1111/ijd.16365. 2022

High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022

Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022

Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021

How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022

How does SCORTEN score?

Navarro, IT; (...); Botella-Estrada, R

Meeting Abstract. 2019

Identification of c.104T>G, p.Met35Arg (NM_00314.8) variant in heterozygosity in exon 2 of the PTEN gene as the Causative Factor for Cowden Syndrome: A Medical Case Study.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1093/ced/llad344. 2023

IMAPSORS project: A multicenter validation study to assess the accuracy of an artificial intelligence solution to quantify psoriasis severity

Martorell, A; (...); Llamas, M

Meeting Abstract. 2021

Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020

Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital.

Simarro, Javier; (...); Palanca, Sarai

Article. 10.3390/cancers15061705. 2023

Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020

Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019

Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020

Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis.

Baniandrés-Rodríguez O; (...); García-Doval I

Letter. 10.1016/j.jaad.2020.10.046. 2021

Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.

García-Ortega A; (...); Martínez-García MÁ

Article. 10.1016/j.jinf.2021.01.003. 2021

Incomplete Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery).

Oro-Ayude, M.; (...); REGESMOHS (Registro Español de Cirugía de Mohs)

Letter. 10.1111/jdv.17597. 2022

Infectious pubic plaque.

Torres-Navarro, Ignacio; (...); Botella-Estrada, Rafael

Editorial Material. 10.1016/j.eimc.2019.03.004. 2019

Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019

Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021

Innovations of Spanish code of medical deontology

Lasheras-Pérez MA; (...); Unamuno Bustos B

Letter. 10.1016/j.semerg.2023.102137. 2024

Interparietal nodule in a 49-year-old woman.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Case Reports. 10.1111/ddg.15398. 2024

Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019

Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020

Invasive scedosporiosis in lung transplant recipients: A nine-year retrospective study in a tertiary care hospital.

Ibáñez-Martínez E; (...); Pemán J

Case Reports. 10.1016/j.riam.2021.06.002. 2021

Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-a-Inhibitoren behandelten Patienten.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.1111/ddg.15007_g. 2023

La eutanasia en el régimen penitenciario español.

Lasheras-Pérez MA; (...); Rodríguez-Serna M

Letter. 10.1016/j.semerg.2024.102219. 2024

Leishmaniasis in patients undergoing biologic and immunosuppressive treatment: Case-control multicenter study

Sahuquillo-Torralba, A; (...); Rocamora, V

Meeting Abstract. 2020

'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.

Mansilla-Polo M, Escutia-Muñoz B, Botella-Estrada R

Article. 10.1007/s15010-024-02214-z. 2024

Longer dupilumab dosing intervals in atopic dermatitis: optimization or therapeutic failure?

Lasheras-Pérez MA, Navarro-Blanco F, Rodríguez-Serna M

Article. 10.1016/j.ad.2023.04.043. 2024

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

Martinez-Camprecios, Joan; (...); Buti, Maria

Article. 10.1016/j.gastrohep.2022.12.004. 2023

Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry

Dauden, E; (...); Garcia-Doval, I

Article. 10.1016/j.jaad.2020.03.033. 2020

Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study.

Rivera R; (...); Carrascosa JM

Letter. 10.1111/jdv.16809. 2020

Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022

Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021

Melanoma and LEOPARD Syndrome: Understanding the Role of PTPN11 Mutations in Melanomagenesis.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.2340/actadv.v104.14720. 2024

Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022

Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020

MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.

Murria Estal, Rosa; (...); Botella Estrada, Rafael

Article. 10.1097/CMR.0000000000000709. 2020

MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase.

Tarazon, Estefania; (...); Botella Estrada, Rafael

Article. 10.3390/genes12121931. 2021

Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience.

Nieto Benito LM; (...); García-Doval I

Case Reports. 10.1016/j.ad.2021.05.017. 2022

Mohs micrographic surgery in dermatofibrosarcoma protuberans: Rate and risk factors for recurrence in a prospective cohort study from the Spanish Registry of Mohs Surgery (REGESMOHS) and review of the literature.

Nieto-Benito LM; (...); Garcia-Doval I

Review. 10.1111/exd.14291. 2021

Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery).

Abril-Pérez C; (...); Botella-Estrada R

Article. 10.1111/jdv.20103. 2024

Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021

Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021

Multiple pilomatricomas in a child with xeroderma pigmentosum: Coincidence or association?

Palacios-Diaz RD; (...); Botella-Estrada R

Article. 10.1111/pde.14924. 2022

Multiple Primary Melanomas: Retrospective Review in a Tertiary Care Hospital

Palacios-Diaz RD; (...); Botella-Estrada R

Article. 10.3390/jcm11092355. 2022

Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.

Article. 10.1016/j.ad.2023.08.001. 2023

Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.

Mansilla-Polo, M., Escutia-Munoz, B., Botella-Estrada, R.

Article. 10.1016/j.ad.2023.05.015. 2023

National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

One Dose Risankizumab Effectiveness in Psoriasis: A Real-Life Multicentre Study

Magdaleno-Tapial, Jorge; (...); Sanchez-Carazo, Jose Luis

Article. 10.1155/2024/4866592. 2024

Pancreatic panniculitis.

Torres-Navarro I, Rojas-Ferrer N, Botella-Estrada R

Article. 10.17235/reed.2019.6116/2018. 2019

Papulonecrotic tuberculides as a key to the diagnosis of tuberculosis: a case report.

Mansilla-Polo, Miguel, Botella-Estrada, Rafael

Letter. 10.1111/ijd.16940. 2024

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022

Paradoxical psoriasiform reactions by anti-TNF treated with Ustekinumab in patients with inflammatory bowel disease

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Meeting Abstract. 2019

Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain.

Docampo-Simon, Alexandre; (...); Silvestre, Juan F.

Article. 10.1089/derm.2022.0023. 2023

Patch testing with formaldehyde 2% aq. - A multicenter study in Spain.

Sanz-Sánchez T; (...); Giménez Arnau AM

Article. 10.1111/cod.13361. 2019

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.

Sánchez-Velázquez A; (...); Ortiz-Romero PL

Letter. 10.1111/jdv.17430. 2021

Personalized medicine to treat atopic dermatitis: in search for predictive biomarkers.

Lasheras-Perez, M A, Navarro-Blanco, F, Rodriguez-Serna, M

Article. 10.1016/j.ad.2023.02.041. 2024

Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020

Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.

Munoz-Aceituno, E.; (...); de la Fuente, H.

Article. 10.1111/jdv.19782. 2023

Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021

Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022

Photosafety of the antidiabetic drug sitagliptin

Dubon, A; (...); ANDREU, I.

Letter. 10.1111/phpp.12475. 2019

PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020

Podoconiosis.

Mansilla-Polo, Miguel, Lopez-Leon, Paula Teresa, Botella-Estrada, Rafael

Article. 10.1001/jamadermatol.2023.4143. 2023

Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis.

Pesque, David; (...); Gimenez-Arnau, Ana Maria

Article. 10.1111/jdv.19934. 2024

Porto sinusoidal vascular liver disorder: natural history and long-term outcome

Magaz, Marta; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023

PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019

Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021

Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021

Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.

Falkenhain-Lopez, D; (...); Ortiz-Romero, P L

Article. 10.1016/j.ad.2022.11.010. 2023

Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry.

Torre-Castro J; (...); Machan S

Article. 10.1111/pde.14811. 2021

Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021

Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study.

Marti-Marti I; (...); Toll A

Article. 10.1016/j.jaad.2023.02.048. 2023

Psoriasis onset over a fresh tattoo.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Article. 10.1016/j.medcli.2022.01.014. 2022

Pyoderma Gangrenosum With Ulcerative Colitis Successfully Treated With Ustekinumab.

Piqueras-García J; (...); Botella-Estrada R

Letter. 10.1016/j.ad.2018.03.034. 2019

Raccoon eyes as a diagnostic key for suspected amyloidosis

Editorial Material. 10.1093/rap/rkad105. 2023

Rationale and study design for an Individualized PeriopeRative Open lung VEntilatory approach in Emergency Abdominal Laparotomy/scopy: study protocol for a prospective international randomized controlled trial.

Laguna G; (...); Ferrando C

Article. 10.1016/j.redare.2024.04.007. 2024

Reactive arthritis.

Article. 10.1016/j.medcli.2023.08.017. 2023

Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.

Ruiz-Cobo, Juan Carlos; (...); Buti, Maria

Article. 10.1111/apt.18020. 2024

Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

Ruiz-Cobo, Juan Carlos; (...); Lens, Sabela

Meeting Abstract. 2023

Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group.

Del Alcázar E; (...); Carrascosa JM

Article. 10.1111/jdv.16439. 2020

Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1111/ajd.14339. 2024

Real-world short-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA Registry

Iborra, M; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.629. 2019

Recalcitrant Hailey-Hailey Disease With Satisfactory Response to Apremilast.

Mansilla-Polo, M; (...); Botella-Estrada, R

Case Reports. 10.1016/j.ad.2023.05.022. 2023

Recalcitrant lichen planopilaris treated with upadacitinib: a case series

Lasheras-Perez, Miguel A.; (...); Botella-Estrada, Rafael

Article. 10.1111/ijd.17339. 2024

Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.

Crespo, Javier; (...); Calleja, Jose Luis

Practice Guideline. 10.1016/j.gastrohep.2022.09.009. 2023

Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease.

Boscá MM; (...); Hinojosa J

Review. 10.1016/j.gastrohep.2019.09.012. 2020

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.

Barreiro-de Acosta M; (...); Nos P

Article. 10.1016/j.gastrohep.2020.04.004. 2020

Recurrent alcohol-associated hepatitis is common and is associated with increased mortality.

Gratacos-Gines, Jordi; (...); Pose, Elisa

Article. 10.1097/HEP.0000000000000825. 2024

Refractory cutaneous lupus erythematosus successfully treated with anifrolumab: a case series.

Martin-Torregrosa, Daniel; (...); Torres-Navarro, Ignacio

Letter. 10.1111/ijd.17022. 2024

Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients.

Feced Olmos CM; (...); Román Ivorra JA

Article. 10.1016/j.clinbiomech.2019.06.009. 2019

Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.

Sanchez-Diaz, M.; (...); Carrascosa-Carrillo, J. M.

Article. 10.1016/j.ad.2023.10.016. 2023

Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)

Tomas-Velazquez, Alejandra; (...); Redondo, Pedro

Article. 10.2340/actadv.v101.544. 2021

Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.

Miñano Medrano R; (...); García-Doval I

Article. 10.1016/j.ad.2022.01.003. 2022

Risk of Hepatitis B Virus Reactivation in Patients on Secukinumab for Psoriasis: A Series of 4 Cases

Moneva-Leniz, LM; (...); Mateu-Puchades, A

Letter. 10.1016/j.ad.2019.02.022. 2020

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial

Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023

Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.

Lluch-Galcera, Juan Jose; (...); Garcia-Doval, Ignacio

Article. 10.1093/bjd/ljad382. 2023

Scaling and periorificial crusts in a pediatric patient.

Fayos-Gregori, Rafael; (...); Botella-Estrada, Rafael

Article. 10.1007/s15010-024-02309-7. 2024

Scalp Melanoma: A High-Risk Subset of Cutaneous Head and Neck Melanomas with Distinctive Clinicopathological Features.

Palacios-Diaz RD; (...); Botella-Estrada R

Article. 10.3390/jcm12247643. 2023

Secukinumab is effective and safe in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.

Reolid, Alejandra; (...); Dauden, Esteban

Article. 10.1016/j.jaad.2022.05.047. 2022

SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020

Sensitisation to textile dyes in Spain: Epidemiological situation (2019-2022).

Hernández Fernández CP; (...); Doval IG

Article. 10.1111/cod.14513. 2024

Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019-2021 epidemiological situation.

Hernandez Fernandez, Carlos Pelayo; (...); Garcia Doval, Ignacio

Article. 10.1111/cod.14251. 2022

Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study.

Tejera-Vaquerizo, Antonio; (...); Nagore, Eduardo

Article. 10.3390/jcm10245878. 2021

SfM-3DULC: Reliability of a new 3D wound measurement procedure and its accuracy in projected area.

Sánchez-Jiménez D; (...); Botella-Estrada R

Article. 10.1111/iwj.13595. 2021

Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC 1 national cross-sectional study.

Mercader-García P; (...); Borrego L

Article. 10.1111/cod.13837. 2021

Single Digital Metastasis of Rectal Adenocarcinoma

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Letter. 10.1097/DAD.0000000000002529. 2023

Skin lesions in a lung transplant recipient

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Editorial Material. 10.1016/j.eimc.2023.09.005. 2024

Skin lesions in a lung transplant recipient.

Case Reports. 10.1016/j.eimce.2023.09.005. 2024

SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022

Sodium metabisulfite a current low relevant allergen in Spain.

Sanz-Sanchez, Tatiana; (...); Borrego, Leopoldo

Letter. 10.1111/jdv.19702. 2023

Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma.

Sanmartín O; (...); Puig S

Review. 10.1016/j.ad.2020.11.002. 2021

Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).

Navarro-Triviño FJ; (...); Carlos Armario-Hita J

Article. 10.1016/j.ad.2024.03.024. 2024

State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS).

Rodríguez-Jiménez P; (...); Descalzo MA

Article. 10.1111/ijd.14732. 2020

Successful treatment of erythema nodosum leprosum with apremilast.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Letter. 10.1111/dth.15258. 2022

Successful treatment of erythema nodosum leprosum with upadacitinib and roflumilast.

Mansilla-Polo, Miguel; (...); Torres-Navarro, Ignacio

Letter. 10.1111/ijd.17293. 2024

Successful treatment of field of cancerization in the dorsum of the hands with 1% tirbanibulin ointment.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Article. 10.1093/ced/llad171. 2023

Successful treatment with imatinib of lymphomatoid papulosis associated with myeloproliferative hypereosinophilic syndrome with PDGFRA rearrangement.

Torres-Navarro I, de Unamuno-Bustos B, Botella-Estrada R

Case Reports. 10.1111/ddg.14064. 2020

Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?

Cabezas, Joaquin; (...); Crespo, Javier

Meeting Abstract. 2023

SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?

Cabezas, Joaquin; (...); Crespo Garcia, Javier

Meeting Abstract. 2023

Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.

Tejera-Vaquerizo, A; (...); SENTIMEL group

Article. 10.1002/cam4.2358. 2019

Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects.

Lasheras-Pérez MA; (...); Rodriguez-Serna M

Article. 10.1111/ijd.16926. 2024

Symmetrical pustulosis unfolds over systemic lupus.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Article. 10.1093/rheumatology/keab529. 2021

Systematic review of BRAF/MEK inhibitors-induced Severe Cutaneous Adverse Reactions (SCARs).

Review. 10.1111/jdv.16894. 2020

Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Megías-Vericat JE; (...); Montesinos P

Review. 10.3390/pharmaceutics14040878. 2022

Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis.

Torres-Navarro I, Briz-Redón Á, Botella-Estrada R

Review. 10.1111/jdv.16685. 2020

Systemic therapies for toxic epidermal necrolysis and Stevens-Johnson syndrome: A SCORTEN-based systematic review and meta-analysis

Torres Navarro, Ignacio; (...); Botella-Estrada, Rafael

Meeting Abstract. 2020

Tattoo-Associated Common Wart.

Mansilla-Polo, M, Llavador-Ros, M, Botella-Estrada, R

Article. 10.1016/j.ad.2023.04.037. 2023

Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients

Simarro, Javier; (...); Palanca, Sarai

Article. 10.3390/ijms23158526. 2022

Telomerase Expression in a Series of Melanocytic Neoplasms

Bustos, BD; (...); Estrada, RB

Article. 10.1016/j.ad.2018.10.003. 2019

The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity

Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar

Article. 10.1007/s00431-022-04628-z. 2022

The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Gil-Nagel A; (...); Gil A

Article. 10.1016/j.yebeh.2022.108711. 2022

The Female Sexual Function Index to assess patients with moderate to severe vulvar lichen sclerosus.

Gutierrez-Ontalvilla P; (...); Vicente D

Letter. 10.1684/ejd.2019.3580. 2019

The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study.

Echarri A; (...); Muñiz J

Article. 10.1089/tmj.2018.0264. 2020

The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry.

Munera-Campos, M; (...); Garcia-Doval, I

Article. 10.1080/09546634.2021.1922572. 2021

The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm registry: a prospective cohort study.

Sahuquillo-Torralba A; (...); García-Doval I

Letter. 10.1016/j.jaad.2019.07.028. 2020

Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020

Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy

Del Rio-Bermudez, C; (...); Poveda, JL

Editorial Material. 10.1186/s40545-020-00276-6. 2020

Toxic epidermal necrolysis with severe hepatic involvement

Torres-Navarro, I; (...); Botella-Estrada, R

Letter. 10.1111/ddg.14110. 2020

Toxische epidermale Nekrolyse mit schwerer hepatischer Beteiligung.